Ha G, Kwong K, Tanaka B, Nishimura Y, Chong C. Are patients with HHV-8 associated Castleman disease successfully treated with rituximab at risk of subsequently developing HHV-8 negative (idiopathic) Castleman disease? iMCD after HHV-8-associated MCD. EJCRIM [Internet]. 2023 Jun. 20 [cited 2026 Nov. 3];10(7). Available from: https://ejcrim.com/index.php/ejcrim/article/view/3904